Following the submission of the BIA’s response to Dame Anne Dowling’s review into business-university research collaborations, this week’s video comes from BIA member AstraZeneca on their collaboration with the Medical Research Council (MRC).

In 2011, a landmark agreement between MRC and AstraZeneca gave UK academic researchers unprecedented access to 22 compounds. These compounds had stalled in early testing, often because they didn’t prove effective against the original target. But they may still be useful against other diseases.

To find out more about the Dowling review and our response, read our press release here.

Do you have a video you would like the sector to see? Contact us.